Giorgio Secreto

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. pmc Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers
    Giorgio Secreto
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    BMC Cancer 12:599. 2012
  2. ncbi request reprint Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer
    Giorgio Secreto
    Hormone Research Laboratory, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Anticancer Res 32:3223-8. 2012
  3. doi request reprint Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study
    Giorgio Secreto
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy
    Int J Biol Markers 26:241-6. 2011
  4. doi request reprint Testosterone and biological characteristics of breast cancers in postmenopausal women
    Giorgio Secreto
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
    Cancer Epidemiol Biomarkers Prev 18:2942-8. 2009
  5. ncbi request reprint Plasma testosterone and prognosis of postmenopausal breast cancer patients
    Andrea Micheli
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    J Clin Oncol 25:2685-90. 2007
  6. ncbi request reprint Serum testosterone levels and breast cancer recurrence
    Franco Berrino
    Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Milan, Italy
    Int J Cancer 113:499-502. 2005
  7. doi request reprint Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis
    Patrizia Pasanisi
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Cancer Epidemiol Biomarkers Prev 17:1719-22. 2008

Collaborators

Detail Information

Publications7

  1. pmc Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers
    Giorgio Secreto
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    BMC Cancer 12:599. 2012
    ..In the present study, we further investigated the role of the androgen/AR pathway in breast cancer development...
  2. ncbi request reprint Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer
    Giorgio Secreto
    Hormone Research Laboratory, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Anticancer Res 32:3223-8. 2012
    ..This classification identifies several different subsets of tumors and may have important clinical implications...
  3. doi request reprint Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study
    Giorgio Secreto
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy
    Int J Biol Markers 26:241-6. 2011
    ..To further investigate the role of sex hormones in breast cancer, we assessed the relations of circulating estradiol and testosterone to tumor size and estrogen receptor (ER) status...
  4. doi request reprint Testosterone and biological characteristics of breast cancers in postmenopausal women
    Giorgio Secreto
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
    Cancer Epidemiol Biomarkers Prev 18:2942-8. 2009
    ..The relationship between testosterone and HER2 status in the oldest patients merits further investigation...
  5. ncbi request reprint Plasma testosterone and prognosis of postmenopausal breast cancer patients
    Andrea Micheli
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    J Clin Oncol 25:2685-90. 2007
    ..High endogenous testosterone is associated with increased breast cancer (BC) risk. We designed this study specifically to assess the long-term prognostic role of testosterone in a cohort of postmenopausal BC patients...
  6. ncbi request reprint Serum testosterone levels and breast cancer recurrence
    Franco Berrino
    Department of Preventive and Predictive Medicine, Istituto Nazionale Tumori, Milan, Italy
    Int J Cancer 113:499-502. 2005
    ..High testosterone predicts breast cancer recurrence. Further studies are required to determine whether dietary or other medical intervention to reduce testosterone can reduce the recurrence of breast cancer...
  7. doi request reprint Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis
    Patrizia Pasanisi
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Cancer Epidemiol Biomarkers Prev 17:1719-22. 2008
    ..The results suggest that PDGF may be an important prognostic factor for breast cancer and that IGF-I may increase the risk of recurrence in the presence of high PDGF levels...